MonikaFischerMD
Gastroenterology • Indianapolis, INAssistant Professor, Medicine, Indiana University School of Medicine
Dr. Fischer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
550 University Blvd
Indianapolis, IN 46202Phone+1 317-312-1242
Education & Training
Indiana University School of MedicineFellowship, Gastroenterology, 2006 - 2011- Indiana University School of MedicineResidency, Internal Medicine, 2004 - 2006
Semmelweis UniversityClass of 1992
Certifications & Licensure
IN State Medical License 2007 - 2025- American Board of Internal Medicine Gastroenterology
Clinical Trials
- Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis Start of enrollment: 2012 Feb 01
- Small Intestinal Bacterial Overgrowth: A Prospective Registry Start of enrollment: 2013 Jan 01
- A Trial of Encapsulated Fecal Microbiota for Vancomycin Resistant Enterococcus Decolonization Start of enrollment: 2017 Aug 17
- Join now to see all
Publications & Presentations
PubMed
- 69 citationsFecal Microbiota Transplantation.Yao-Wen Cheng, Monika Fischer
Clinics in Colon and Rectal Surgery. 2023-03-01 - 43 citationsComparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease.Matthew Bohm, Ronghui Xu, Yiran Zhang, Sashidhar Varma, Monika Fischer
Alimentary Pharmacology & Therapeutics. 2020-08-01 - 53 citationsVedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.Neeraj Narula, Farhad Peerani, Joseph Meserve, Gursimran Kochhar, Khadija Chaudrey
The American Journal of Gastroenterology. 2018-09-01
Journal Articles
- Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumLeah Katta, Robert Hirten, Shannon Chang, Dana Lukin, Edward V Loftus, David Faleck, Arun Swaminath, William J Sandborn, Sashidhar Varma Sagi, Sunanda Kane, Prianka Ch..., Nature
- Fecal Microbiota Transplantation for the Treatment of Recurrent and Severe Clostridium Difficile Infection in Solid Organ Transplant Recipients: A Multicenter ExperienceRaj Vuppalanchi, Adam Ehrlich, Michael Smith, Asif Sharfuddin, Nasia Safdar, Nirmal Kaur, Elizabeth Ann Misch, Monika Fischer, Ann Flynn, Vincent Ganapini, Michael H W..., American journal of transplantation
- Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumGursimran Kochhar, Justin Hartke, Sashidhar Varma Sagi, Edward V Loftus, Joseph Meserve, Robert Hirten, David Faleck, Shannon Chang, Dana Lukin, Farhad Peerani, Leah K..., Nature
Press Mentions
Antibiotics plus Oral Fecal Microbiota Transplantation Tied to Ulcerative Colitis RemissionDecember 28th, 2021- Fecal Transplants: A New Treatment for IBDSeptember 9th, 2021
- American College of Gastroenterology Issues Updated Clinical Guidelines for C. Difficile InfectionMay 19th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
